comparemela.com

Latest Breaking News On - Anticancer therapies congress - Page 2 : comparemela.com

ESMO Congress 2024: Shaping the future of anticancer therapies

The ESMO Targeted Anticancer Therapies Congress 2024 is the annual multi-stakeholder meeting that focuses on the development of novel anticancer therapies and how this can transform the current knowledge and impact clinical care.

ESMO Targeted Anticancer Therapies Congress 2024: Event announcement

The ESMO Targeted Anticancer Therapies Congress 2024 is the annual multi-stakeholder meeting that focuses on the development of novel anticancer thera..

Onxeo Reports Full Year 2022 Financial Results and Provides Clinical Development Updates

Phase 1b/2 trial of AsiDNA™ in combination with olaparib in the United States in recurrent ovarian, breast and metastatic castration-resistant prostate cancer continues to enroll. | April 24, 2023

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.